申请人:Burgdorf Lars Thore
公开号:US20100210690A1
公开(公告)日:2010-08-19
Novel heterocyclic compounds of the formula I
in which R
1
, R
2
, R
3
, R
4
, R
5
, R
6
, R
7
, Alk and D have the meanings indicated in claim
1,
are activators of glucokinase and can be used for the prevention and/or treatment of Diabetes Typ 1 and 2, obesity, neuropathy and/or nephropathy.
式I中的新型杂环化合物,其中R1,R2,R3,R4,R5,R6,R7,Alk和D具有权利要求1中所示的含义,是葡萄糖激酶的激活剂,可用于预防和/或治疗1型和2型糖尿病、肥胖症、神经病和/或肾病。